You are viewing an incomplete version of our website. Please click to reload the website as full version.

D-Amino Acid Oxidase Activator (DAOA) (C-Term) Peptide

Details for Product No. ABIN695258, Supplier: Log in to see
Protein Name
  • LG72
  • SG72
  • DAO
  • MGC114783
  • daao
  • oxda
  • damox
  • DKFZp469N2232
Protein Region
C-Term
Source
Synthetic
Peptide Type
Synthetic
Application
Blocking Peptide (BP)
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Background DAOA is a protein that is an activator of the FAD-dependent enzyme D-amino acid oxidase, which degrades the gliotransmitter D-serine, a potent activator of N-methyl-D-aspartate (NMDA) type glutamate receptors. Polymorphisms in this gene have been implicated in susceptibility to schizophrenia and bipolar affective disorder, possibly due to decreased levels of D-serine and decreased NMDA receptor functioning.
Restrictions For Research Use only
Storage 4
Storage Comment Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Expiry Date 6 months
Background publications Schumacher, Jamra, Freudenberg et al.: "Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder." in: Molecular psychiatry, Vol. 9, Issue 2, pp. 203-7, 2004 (PubMed).

Hattori, Liu, Badner et al.: "Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series." in: American journal of human genetics, Vol. 72, Issue 5, pp. 1131-40, 2003 (PubMed).

Chumakov, Blumenfeld, Guerassimenko et al.: "Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 99, Issue 21, pp. 13675-80, 2002 (PubMed).